1. Home
  2. KRNY vs IPSC Comparison

KRNY vs IPSC Comparison

Compare KRNY & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kearny Financial Corp

KRNY

Kearny Financial Corp

HOLD

Current Price

$8.57

Market Cap

526.7M

Sector

Finance

ML Signal

HOLD

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.20

Market Cap

441.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRNY
IPSC
Founded
1884
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
526.7M
441.9M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
KRNY
IPSC
Price
$8.57
$2.20
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$9.25
$4.25
AVG Volume (30 Days)
297.8K
906.8K
Earning Date
04-23-2026
05-11-2026
Dividend Yield
5.45%
N/A
EPS Growth
130.22
91.30
EPS
0.46
N/A
Revenue
$2,580,000.00
$109,164,000.00
Revenue This Year
$3.89
N/A
Revenue Next Year
$17.52
N/A
P/E Ratio
$18.78
N/A
Revenue Growth
36.00
1556.76
52 Week Low
$5.76
$0.44
52 Week High
$8.67
$2.97

Technical Indicators

Market Signals
Indicator
KRNY
IPSC
Relative Strength Index (RSI) 63.52 49.45
Support Level $7.77 $2.13
Resistance Level N/A $2.45
Average True Range (ATR) 0.17 0.16
MACD 0.04 -0.01
Stochastic Oscillator 77.92 44.95

Price Performance

Historical Comparison
KRNY
IPSC

About KRNY Kearny Financial Corp

Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. The bank's primary source of income is net interest income.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

Share on Social Networks: